Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a Phase-II and observation study (EORTC 22042-26042)
Phase 2
- Conditions
- atypical and malignant meningioma10029211
- Registration Number
- NL-OMON32223
- Lead Sponsor
- EORTC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
summary of protocol page 22:
Adult patients in a fair condition after resection of an intracranial atypical or malignant meningioma.
Exclusion Criteria
not D4a
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Disease free survival</p><br>
- Secondary Outcome Measures
Name Time Method <p>Toxicity</p><br>